Is Tesamorelin legal in Florida?
FDA-approved GHRH analogue (Egrifta) for HIV lipodystrophy; WADA S2.2 explicitly prohibited; 'research-grade' tesamorelin from retail vendors is unapproved diversion. Florida § 893.03(3) (HB 1041, eff. 2013-10-01) lists tesamorelin and 'GHRH' as Schedule III controlled substances. Possession/distribution triggers state controlled-substance penalties.
CATEGORY · FDA APPROVED
Full status breakdown
FEDERAL · STATE · SPORT-BODYFederal status
Florida — state-specific
Florida § 893.03(3) (HB 1041, eff. 2013-10-01) lists tesamorelin and 'GHRH' as Schedule III controlled substances. Possession/distribution triggers state controlled-substance penalties.
- Florida HB 1041 (2013) bill analysis ↗ · verified May 13, 2026
Sport-body status
What we couldn’t verify
Also known as
5 ALIASESTesamorelin is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
EgriftaEgrifta SVEgrifta WRTH9507GHRH analogue
Related
FOLLOW-ONS- Back to peptide legality lookup — pick a different compound or state
- Tesamorelin research guide — mechanism, dosing math, vendor audits, COA data
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
Tesamorelin legality in other US states
State-by-state legal status for the same compound. Federal classification holds, state law varies.